Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06757244
Title DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 with MFOLFIRINOX in PAncreatic Cancer (DOVIPA)
Acronym DOVIPA
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hopital Foch
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.